Cargando…

Dopamine D(1), D(2), D(3) Receptors, Vesicular Monoamine Transporter Type-2 (VMAT2) and Dopamine Transporter (DAT) Densities in Aged Human Brain

The dopamine D(1), D(2), D(3) receptors, vesicular monoamine transporter type-2 (VMAT2), and dopamine transporter (DAT) densities were measured in 11 aged human brains (aged 77–107.8, mean: 91 years) by quantitative autoradiography. The density of D(1) receptors, VMAT2, and DAT was measured using [(...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jianjun, Xu, Jinbin, Cairns, Nigel J., Perlmutter, Joel S., Mach, Robert H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504049/ https://www.ncbi.nlm.nih.gov/pubmed/23185343 http://dx.doi.org/10.1371/journal.pone.0049483

Ejemplares similares

No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson Disease
por: Tian, LinLin, et al.
Publicado: (2012)

Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent
por: Jiang, Donglang, et al.
Publicado: (2019)

Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions
por: Alwindi, Malik, et al.
Publicado: (2023)

Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas
por: Saisho, Yoshifumi, et al.
Publicado: (2008)

Associations Between the Dopamine D4 Receptor and DAT1 Dopamine Transporter Genes Polymorphisms and Personality Traits in Addicted Patients
por: Chmielowiec, Jolanta, et al.
Publicado: (2018)

Dopamine Transporter (DAT1) and Dopamine Receptor D4 (DRD4) Genotypes Differentially Impact on Electrophysiological Correlates of Error Processing
por: Biehl, Stefanie C., et al.
Publicado: (2011)

Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features
por: Yang, Pengfei, et al.
Publicado: (2020)

Dopamine and vesicular monoamine transport loss supports incidental Lewy body disease as preclinical idiopathic Parkinson
por: Pifl, Christian, et al.
Publicado: (2023)

Insights to ligand binding to the monoamine transporters—from homology modeling to LeuBAT and dDAT
por: Koldsø, Heidi, et al.
Publicado: (2015)

Functional genetic variants in the vesicular monoamine transporter 1 (VMAT1) modulate emotion processing
por: Lohoff, Falk W., et al.
Publicado: (2013)

Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion
por: Blanco-Lezcano, Lisette, et al.
Publicado: (2018)

The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density
por: VanNess, Sidney H, et al.
Publicado: (2005)

Presence and Function of Dopamine Transporter (DAT) in Stallion Sperm: Dopamine Modulates Sperm Motility and Acrosomal Integrity
por: Urra, Javier A., et al.
Publicado: (2014)

Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice
por: Cataldi, Stefano, et al.
Publicado: (2018)

Vesicular monoamine transporter, type 2 (vmat2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas
por: Freeby, Matthew, et al.
Publicado: (2012)

Association study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese population
por: Richards, Misty, et al.
Publicado: (2006)

The ins and outs of vesicular monoamine transporters
por: Yaffe, Dana, et al.
Publicado: (2018)

Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson’s disease
por: Brighina, Laura, et al.
Publicado: (2013)

Preclinical Efficacy of Novel Vesicular Monoamine Transporter 2 Inhibitors as Antagonists of d-Methamphetamine Self-Administration in Rats
por: Hiranita, Takato
Publicado: (2015)

Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor
por: Sotnikova, Tatyana D., et al.
Publicado: (2020)

Living without DAT: Loss and compensation of the dopamine transporter gene in sauropsids (birds and reptiles)
por: Lovell, P. V., et al.
Publicado: (2015)

Methylation in the Promoter Region of the Dopamine Transporter DAT1 Gene in People Addicted to Nicotine
por: Chmielowiec, Jolanta, et al.
Publicado: (2022)

DNA Methylation of the Dopamine Transporter DAT1 Gene—Bliss Seekers in the Light of Epigenetics
por: Chmielowiec, Krzysztof, et al.
Publicado: (2023)

Role of Vesicular Monoamine Transporter 2 Inhibitors in Tardive Dyskinesia Management
por: Sreeram, Venkatesh, et al.
Publicado: (2019)

Implications for Combination Therapy of Selective Monoamine Reuptake Inhibitors on Dopamine Transporters
por: Ahn, Hyomin, et al.
Publicado: (2023)

Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists
por: Pogorelov, Vladimir M., et al.
Publicado: (2023)

Selenoprotein P Modulates Methamphetamine Enhancement of Vesicular Dopamine Release in Mouse Nucleus Accumbens Via Dopamine D2 Receptors
por: Torres, Daniel J., et al.
Publicado: (2021)

Selective Knockout of the Vesicular Monoamine Transporter 2 (Vmat2) Gene in Calbindin2/Calretinin-Positive Neurons Results in Profound Changes in Behavior and Response to Drugs of Abuse
por: König, Niclas, et al.
Publicado: (2020)

Modelling brain dopamine-serotonin vesicular transport disease in Caenorhabditis elegans
por: Young, Alexander T., et al.
Publicado: (2018)

Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1)
por: Mill, Jonathan, et al.
Publicado: (2005)

Dopaminergic Control of Attentional Flexibility: Inhibition of Return is Associated with the Dopamine Transporter Gene (DAT1)
por: Colzato, Lorenza S., et al.
Publicado: (2010)

Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation
por: Navratna, Vikas, et al.
Publicado: (2018)

Epigenetic Analysis of the Dopamine Transporter Gene DAT1 with a Focus on Personality Traits in Athletes
por: Humińska-Lisowska, Kinga, et al.
Publicado: (2023)

Methamphetamine Increases Locomotion and Dopamine Transporter Activity in Dopamine D5 Receptor-Deficient Mice
por: Hayashizaki, Seiji, et al.
Publicado: (2013)

Identification of the mRNA Expression Status of the Dopamine D2 Receptor and Dopamine Transporter in Peripheral Blood Lymphocytes of Schizophrenia Patients
por: Liu, Liang, et al.
Publicado: (2013)

Single and Binge Methamphetamine Administrations Have Different Effects on the Levels of Dopamine D2 Autoreceptor and Dopamine Transporter in Rat Striatum
por: Chauhan, Heli, et al.
Publicado: (2014)

PT545. The Direct Protein-Protein Interaction between Dopamine Transporter and Dopamine D2 Receptor: A Novel Target Site to Modulate Synaptic Dopamine
por: Lai, Terence K.Y., et al.
Publicado: (2016)

Analysis of Polymorphic Variants of the Dopamine Transporter (DAT1) Gene Polymorphism and Personality Traits Among Athletes
por: Michałowska-Sawczyn, Monika, et al.
Publicado: (2020)

Sex-dependent alterations in behavior, drug responses and dopamine transporter expression in heterozygous DAT-Cre mice
por: Costa, Kauê Machado, et al.
Publicado: (2021)

Associations Between Physical Effort and DNA Methylation in the Promotor Region of the Dopamine Transporter Gene (DAT1)
por: Michałowska-Sawczyn, Monika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ekc52t0ke1pe1uagdpasodn9q